Original Contributions |
From the Centro Prevenzione Arteriosclerosi (S.B., M.R.), Università di Genova, Genova; and the Dipartimento di Scienze Biomediche (S. Cassanelli, R.G., M.G., M.L.S., S. Calandra), Università di Modena, Modena, Italy.
Correspondence to Sebastiano Calandra, MD, Dipartimento di Scienze Biomediche, Università di Modena, Via Campi 287, I-41100 Modena, Italy. E-mail sebcal{at}unimo.it
AbstractThe aim of this
study was the characterization of mutations of the LDL receptor gene in
39 Italian patients with homozygous familial
hypercholesterolemia, who were examined during
the period 1994 to 1996. The age of the patients ranged from 1 to 64
years; one third of them were older than 30. Plasma LDL
cholesterol level ranged from 10.8 to 25.1 mmol/L. The
residual LDL receptor activity, measured in cultured fibroblasts of 32
patients, varied from <2% to 30% of normal and was inversely
correlated with the plasma LDL cholesterol level
(r=-0.665; P<0.003). The most severe
coronary atherosclerosis was observed in those
patients with the lowest residual LDL receptor activity (
5% of
normal) and the highest plasma LDL cholesterol levels.
Twenty-nine patients (23 of whom were unrelated) were found to be
homozygotes at the LDL receptor locus. In this group we discovered 2
major rearrangements and 12 different point mutations (9 in the coding
region and 3 in splice sites). Some mutations (D200G, C358R, V502M,
G528D, and P664L) were found in 3 or more unrelated patients.
Patients with the same mutation shared the same haplotype at the LDL
receptor gene locus and came from the same geographic area. Ten
patients (9 of whom were unrelated) were found to be compound
heterozygotes. The mutations found in this group consisted of one large
deletion and 12 point mutations (11 in the coding sequence and one in a
splice site). In 3 compound heterozygotes we failed to identify the
second mutant allele at the LDL receptor locus. These observations
confirm the allelic heterogeneity underlying familial
hypercholesterolemia in the Italian population
and indicate that the variability of phenotypic expression of
homozygous familial hypercholesterolemia is, to
a large extent, related to the type of mutation of the LDL receptor
gene.
Key Words: homozygous familial hypercholesterolemia LDL receptor gene mutational analysis
This article has been cited by other articles:
![]() |
S. Bertolini, A. Cantafora, M. Averna, C. Cortese, C. Motti, S. Martini, G. Pes, A. Postiglione, C. Stefanutti, I. Blotta, et al. Clinical Expression of Familial Hypercholesterolemia in Clusters of Mutations of the LDL Receptor Gene That Cause a Receptor-Defective or Receptor-Negative Phenotype Arterioscler Thromb Vasc Biol, September 1, 2000; 20 (9): e41 - e52. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Deiana, R. Garuti, G. M. Pes, C. Carru, A. Errigo, M. Rolleri, L. Pisciotta, P. Masturzo, A. Cantafora, S. Calandra, et al. Influence of {beta}0-Thalassemia on the Phenotypic Expression of Heterozygous Familial Hypercholesterolemia : A Study of Patients With Familial Hypercholesterolemia From Sardinia Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 236 - 243. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |